Blood test to help decide if a prostate biopsy is needed
Part of Cancer, Kidney & urinary clinical trials.
This study tests a new blood test (Proclarix) that may help doctors decide if a prostate biopsy is needed. It is for men with a slightly elevated PSA who are already considering a biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 40 and 75 years old.
- Your recent PSA test (within 90 days) was between 2 and 10 ng/mL.
- You are planning to discuss a possible prostate biopsy with your doctor.
- You have never been diagnosed with prostate cancer.
- You have not had a prostate biopsy or certain prostate procedures in the last 6 months.
- You have not had a prostate MRI in the last 90 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new blood test (Proclarix) to see if it can better predict prostate cancer risk in men who are already scheduled for an MRI and prostate biopsy. The goal is to improve how doctors decide who needs a biopsy.
This study is testing a new blood test, ClarityDX Prostate, to see if it can help doctors better decide who needs a biopsy. It is for men who have been referred to a urologist because there is a suspicion of prostate cancer but who have not been diagnosed yet.
This study uses a blood test to detect prostate cancer more accurately than traditional methods. It looks for genetic material from cancer cells to help decide if a prostate biopsy is needed.
This study checks whether certain blood markers can help predict how well people with prostate cancer will respond to therapy. It may help doctors choose the most effective treatment sooner by using information from your blood.
This trial tests a new blood test to help decide if you need a prostate biopsy. It may help men with high PSA levels or an abnormal rectal exam avoid unnecessary procedures.
This study uses a simple blood test to look for microRNA patterns that may help spot prostate cancer earlier and avoid unnecessary biopsies. If you have elevated PSA or suspicious findings, this test might give more information about your risk.
Hear when a new Prostate Cancer Detection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.